Claire Skentelbery | Director General
EuropaBio
Claire holds a PhD in biochemistry and has led organisations that champion and advocate for commercial delivery of science for 25 years, starting within the Cambridge UK biotechnology cluster. She has worked to champion biotechnology across sectors through the Council of European BioRegions and the European Biotechnology Network before moving to the Nanotechnology Industries Association. She joined EuropaBio in 2020 and in addition to her current role as Director General, she is also the Vice Chair of the International Council of Biotechnology Associations (ICBA) and Governing Board Member for the Innovative Health Initiative (IHI).
Appearances:
Day 1 - Wednesday 23 October @ 14:00
Chair's opening remarks
Day 1 - Wednesday 23 October @ 16:40
Panel: EU General Pharmaceutical Legislation – Europe’s Biotech Innovation for Rare Diseases in the Balance?
On 24 January 2024, EuropaBio published a new study analysing the expected impact of the GPL on the biotechnology innovation ecosystem which concluded that the GPL would have significant impact on innovation for rare diseases in the future.
-What would be the expected impact of the GPL on biotech innovation and innovators for rare diseases?
-What improvements can be made to ensure a sustained flow and growth of biotech innovation for rare diseases?
Day 3 - Friday 25th October @ 11:10
Panel: A New Beginning? The EU Biotechnology and Biomanufacturing Initiative Opportunities for Investment into Rare Disease Innovation and delivery
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events